Literature DB >> 20569646

Options for the treatment of febrile catatonia.

Georg Northoff1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20569646      PMCID： PMC2895149          DOI： 10.1503/jpn.100087

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  6 in total

Review 1.  Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology.

Authors:  G Northoff
Journal:  J Neural Transm (Vienna)       Date:  2002-12       Impact factor: 3.575

Review 2.  Catatonia: clinical aspects and neurobiological correlates.

Authors:  Jessica Daniels
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

3.  Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam.

Authors:  P I Rosebush; A M Hildebrand; B G Furlong; M F Mazurek
Journal:  J Clin Psychiatry       Date:  1990-09       Impact factor: 4.384

4.  Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine.

Authors:  G Northoff; J Eckert; J Fritze
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

Review 5.  Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes.

Authors:  Brendan T Carroll; Harold W Goforth; Christopher Thomas; Niraj Ahuja; William W McDaniel; Marilyn F Kraus; David R Spiegel; Kathleen N Franco; Leopold Pozuelo; Camilo Muñoz
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

Review 6.  What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis.

Authors:  Georg Northoff
Journal:  Behav Brain Sci       Date:  2002-10       Impact factor: 12.579
  6 in total
  1 in total

Review 1.  What Can Different Motor Circuits Tell Us About Psychosis? An RDoC Perspective.

Authors:  Vijay A Mittal; Jessica A Bernard; Georg Northoff
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.